泰林生物(300813.SZ):近期共取得6項專利證書
格隆匯8月9日丨泰林生物(300813.SZ)公佈,公司全資子公司浙江泰林醫學工程有限公司(“泰林醫學工程”)、浙江泰林生命科學有限公司(“泰林生命科學”)、浙江泰林分析儀器有限公司(“泰林分析儀器”)於近期共取得了6項專利證書,分別為一種定量盤檢測的培養、自動計數和追溯系統,一種可批量化檢測的壓力蒸汽滅菌生物指示劑抗力檢測系統,總有機碳分析儀,自動菌落計數器,過氧化氫汽化消毒機,多功能負壓隔離器。
上述專利的取得不會對泰林醫學工程、泰林生命科學、泰林分析儀器近期生產經營產生重大影響,但有利於泰林醫學工程、泰林生命科學、泰林分析儀器進一步完善知識產權保護體系,發揮自主知識產權優勢,並形成持續創新機制,保持技術領先地位,提升核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.